Mohammad Tariq Ali Khan, Sumaiya Said Al-Siyabi, Hamada E Ali, Raeid M M Abed
{"title":"Removal of hexavalent chromium by a microbial mat from a mining site under anaerobic conditions.","authors":"Mohammad Tariq Ali Khan, Sumaiya Said Al-Siyabi, Hamada E Ali, Raeid M M Abed","doi":"10.3389/fbioe.2025.1585237","DOIUrl":null,"url":null,"abstract":"<p><p>Mining activities have contributed to increased contamination of groundwater with hexavalent chromium (Cr(VI)). Microbial mats have been shown to effectively remove Cr(VI) under aerobic conditions, however, their role in Cr(VI) removal under anaerobic conditions remained unexplored. This study investigates the removal of Cr(VI) by a microbial mat collected from a chromite mining site under anaerobic conditions, as well as the underlying mechanism(s). Removal rates of Cr(VI) increased from 0.15 ± 0.01 to 0.77 ± 0.05 mg L<sup>-1</sup> d<sup>-1</sup> when the mat was incubated at increasing concentrations from 5 to 50 mg L<sup>-1</sup>, respectively. Biosorption was facilitated by the increased production of extracellular polymeric substances (EPS) after exposure to Cr(VI) with the involvement of functional groups such as metal-O, Cr(VI)-O, PO<sub>4</sub>, C-N, C=O, C-H, Alkyl, and OH-NH<sub>2</sub>. The mat could also reduce Cr(VI) to Cr(III) using chromate reductase enzyme. MiSeq sequencing demonstrated clear shifts in the bacterial community structure in favor of Clostridia and Bacilli at 1 mg L<sup>-1</sup> Cr(VI), Gammaproteobacteria at 5 mg L<sup>-1</sup> Cr(VI), and Alphaproteobacteria at the concentrations of 15-50 mg L<sup>-1</sup> Cr(VI). We conclude that microbial mats contain obligate and facultative anaerobic bacteria that possess the ability to remove Cr(VI) under low fluctuating oxygen levels by biosorption on cell surface and enzymatic reduction to Cr(III).</p>","PeriodicalId":12444,"journal":{"name":"Frontiers in Bioengineering and Biotechnology","volume":"13 ","pages":"1585237"},"PeriodicalIF":4.8000,"publicationDate":"2025-09-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12463898/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Bioengineering and Biotechnology","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.3389/fbioe.2025.1585237","RegionNum":3,"RegionCategory":"工程技术","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Mining activities have contributed to increased contamination of groundwater with hexavalent chromium (Cr(VI)). Microbial mats have been shown to effectively remove Cr(VI) under aerobic conditions, however, their role in Cr(VI) removal under anaerobic conditions remained unexplored. This study investigates the removal of Cr(VI) by a microbial mat collected from a chromite mining site under anaerobic conditions, as well as the underlying mechanism(s). Removal rates of Cr(VI) increased from 0.15 ± 0.01 to 0.77 ± 0.05 mg L-1 d-1 when the mat was incubated at increasing concentrations from 5 to 50 mg L-1, respectively. Biosorption was facilitated by the increased production of extracellular polymeric substances (EPS) after exposure to Cr(VI) with the involvement of functional groups such as metal-O, Cr(VI)-O, PO4, C-N, C=O, C-H, Alkyl, and OH-NH2. The mat could also reduce Cr(VI) to Cr(III) using chromate reductase enzyme. MiSeq sequencing demonstrated clear shifts in the bacterial community structure in favor of Clostridia and Bacilli at 1 mg L-1 Cr(VI), Gammaproteobacteria at 5 mg L-1 Cr(VI), and Alphaproteobacteria at the concentrations of 15-50 mg L-1 Cr(VI). We conclude that microbial mats contain obligate and facultative anaerobic bacteria that possess the ability to remove Cr(VI) under low fluctuating oxygen levels by biosorption on cell surface and enzymatic reduction to Cr(III).
期刊介绍:
The translation of new discoveries in medicine to clinical routine has never been easy. During the second half of the last century, thanks to the progress in chemistry, biochemistry and pharmacology, we have seen the development and the application of a large number of drugs and devices aimed at the treatment of symptoms, blocking unwanted pathways and, in the case of infectious diseases, fighting the micro-organisms responsible. However, we are facing, today, a dramatic change in the therapeutic approach to pathologies and diseases. Indeed, the challenge of the present and the next decade is to fully restore the physiological status of the diseased organism and to completely regenerate tissue and organs when they are so seriously affected that treatments cannot be limited to the repression of symptoms or to the repair of damage. This is being made possible thanks to the major developments made in basic cell and molecular biology, including stem cell science, growth factor delivery, gene isolation and transfection, the advances in bioengineering and nanotechnology, including development of new biomaterials, biofabrication technologies and use of bioreactors, and the big improvements in diagnostic tools and imaging of cells, tissues and organs.
In today`s world, an enhancement of communication between multidisciplinary experts, together with the promotion of joint projects and close collaborations among scientists, engineers, industry people, regulatory agencies and physicians are absolute requirements for the success of any attempt to develop and clinically apply a new biological therapy or an innovative device involving the collective use of biomaterials, cells and/or bioactive molecules. “Frontiers in Bioengineering and Biotechnology” aspires to be a forum for all people involved in the process by bridging the gap too often existing between a discovery in the basic sciences and its clinical application.